씨젠
096530UNKNOWN· 의료용 물질 및 의약품 제조업33,800원+100 (+0.30%)전일 종가 2026-09-18
52주 위치
21,70035,75086%신고가 대비 -5.45%
- 시가총액
- 1.8조1조 7,652억
- PBR
- 1.70
- BPS
- 19,894원
- 배당수익률
- 2.96%
- 자사주비율
- 12.76%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE | 49.62% | 16.34% | 0.06% | -2.03% | 4.84% |
| ROA | 36.08% | 12.67% | 0.06% | -1.65% | 3.97% |
| 영업이익률 | 48.63% | 23.02% | -8.18% | -3.98% | 7.29% |
| 순이익률 | 39.21% | 21.37% | 0.20% | -4.89% | 10.22% |
| 매출총이익률 | 73.30% | 58.12% | 57.68% | 57.60% | 64.08% |
| 부채비율 | 37.48% | 20.91% | 21.45% | 22.80% | 21.66% |
| 유동비율 | 367.39% | 530.28% | 483.18% | 462.25% | 467.81% |
| 매출 성장률(YoY) | — | -37.73% | -56.96% | 12.76% | 14.48% |
| 영업이익 성장률(YoY) | — | -70.53% | -115.29% | — | — |
| 순이익 성장률(YoY) | — | -66.06% | -99.60% | -2864.59% | — |
| FCF | 2,724억 | 2,557억 | 698억 | 454억 | 1,120억 |
| FCF 마진 | 19.87% | 29.96% | 18.99% | 10.96% | 23.61% |
| CAPEX/매출 | 4.50% | 7.41% | 6.85% | 9.65% | 7.88% |
| 항목 | 2021 3Q | 2021 4Q | 2022 1Q | 2022 2Q | 2022 3Q | 2022 4Q | 2023 1Q | 2023 2Q | 2023 3Q | 2023 4Q | 2024 1Q | 2024 2Q | 2024 3Q | 2024 4Q | 2025 1Q | 2025 2Q | 2025 3Q | 2025 4Q | 2026 1Q | 2026 2Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.00% | 15.14% | 13.43% | 2.10% | -1.05% | 0.23% | 0.18% | -0.23% | -0.42% | 0.54% | -0.20% | 2.29% | 0.16% | -4.38% | 2.85% | -0.01% | 1.44% | 0.50% | 3.43% | 2.56% |
| ROA | 7.35% | 10.97% | 9.86% | 1.67% | -0.83% | 0.20% | 0.14% | -0.19% | -0.35% | 0.45% | -0.15% | 1.89% | 0.14% | -3.59% | 2.33% | -0.01% | 1.18% | 0.41% | 2.79% | 2.09% |
| 영업이익률 | 42.12% | 48.76% | 44.23% | 10.12% | -21.38% | 13.08% | -15.30% | -11.38% | -10.99% | 3.46% | -15.98% | -1.13% | 4.83% | -5.40% | 12.80% | 2.76% | 8.46% | 5.32% | 18.24% | 15.88% |
| 순이익률 | 30.54% | 39.85% | 36.71% | 19.53% | -7.47% | 2.37% | 2.26% | -3.04% | -5.09% | 5.93% | -2.20% | 24.03% | 1.60% | -38.23% | 24.94% | -0.06% | 12.86% | 3.82% | 26.91% | 19.09% |
| 매출총이익률 | 67.61% | 74.82% | 66.17% | 68.52% | 18.74% | 66.02% | 53.27% | 55.88% | 57.99% | 62.88% | 56.54% | 63.47% | 62.47% | 48.74% | 67.85% | 60.69% | 62.63% | 64.94% | 67.13% | 69.68% |
| 부채비율 | 36.30% | 37.48% | 36.16% | 25.48% | 20.95% | 20.91% | 22.51% | 20.41% | 20.42% | 21.45% | 22.04% | 21.52% | 21.45% | 22.80% | 23.01% | 22.02% | 21.37% | 21.66% | 22.71% | 21.81% |
| 유동비율 | 347.30% | 367.39% | 373.32% | 553.98% | 550.46% | 530.28% | 476.20% | 524.62% | 515.92% | 483.18% | 477.68% | 502.67% | 491.04% | 462.25% | 456.31% | 471.29% | 483.19% | 467.81% | 446.05% | 461.76% |
| 매출 성장률(YoY) | — | — | — | — | -50.59% | -70.05% | -80.05% | -33.88% | -39.09% | -18.17% | -0.11% | 17.91% | 18.43% | 14.75% | 28.96% | 13.90% | 4.34% | 13.26% | 11.33% | 19.20% |
| 영업이익 성장률(YoY) | — | — | — | — | -125.07% | -91.97% | -106.90% | -174.33% | — | -78.35% | — | — | — | -279.14% | — | — | 82.80% | — | 58.63% | 586.36% |
| 순이익 성장률(YoY) | — | — | — | — | -112.08% | -98.22% | -98.77% | -110.31% | — | 104.93% | -197.25% | — | — | -839.88% | — | -100.30% | 737.13% | — | 20.12% | — |
| FCF | 1,640억 | 937억 | 2,407억 | 12.66억 | -47.62억 | 185억 | 304억 | 51.48억 | 135억 | 207억 | 104억 | 128억 | 315억 | -91.72억 | 459억 | 18.7억 | 299억 | 344억 | 283억 | 73.39억 |
| FCF 마진 | 53.73% | 22.85% | 53.32% | 0.99% | -3.16% | 15.10% | 33.79% | 6.06% | 14.73% | 20.56% | 11.51% | 12.73% | 28.91% | -7.95% | 39.54% | 1.64% | 26.31% | 26.31% | 21.94% | 5.40% |
| CAPEX/매출 | 5.97% | 4.39% | 5.00% | 16.65% | 5.77% | 8.63% | 7.33% | 6.38% | 7.10% | 6.57% | 7.12% | 7.31% | 10.29% | 13.07% | 8.51% | 7.66% | 6.44% | 8.76% | 8.81% | 21.27% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 04:49· 연결 · 산식은 항목 툴팁